ANKK1, TTC12, and NCAM1 polymorphisms and heroin dependence: Importance of considering drug exposure

Authors

Elliot C. Nelson, Washington University School of Medicine in St. Louis
Michael T. Lynskey, Washington University School of Medicine in St. LouisFollow
Andrew C. Heath, Washington University School of Medicine in St. LouisFollow
Naomi Wray, University of Queensland
Arpana Agrawal, Washington University School of Medicine in St. LouisFollow
Fiona L. Shand, University of New South Wales, Sydney
Anjali K. Henders, Queensland Institute of Medical ResearchFollow
Leanne Wallace, Queensland Institute of Medical Research
Alexandre A. Todorov, Washington University School of Medicine in St. Louis
Andrew J. Schrage, Washington University School of Medicine in St. Louis
Nancy L. Saccone, Washington University School of Medicine in St. Louis
Pamela A.F Madden, Washington University School of Medicine in St. LouisFollow
Louisa Degenhardt, University of New South Wales, SydneyFollow
Nicholas G. Martin, Queensland Institute of Medical Research
Grant W. Montgomery, Queensland Institute of Medical Research

Document Type

Article

Journal

JAMA Psychiatry

Publication Date

2013

Notes

doi:10.1001/jamapsychiatry.2013.282

Recommended Citation

Nelson, Elliot C.; Lynskey, Michael T.; Heath, Andrew C.; Wray, Naomi; Agrawal, Arpana; Shand, Fiona L.; Henders, Anjali K.; Wallace, Leanne; Todorov, Alexandre A.; Schrage, Andrew J.; Saccone, Nancy L.; Madden, Pamela A.F; Degenhardt, Louisa; Martin, Nicholas G.; and Montgomery, Grant W., "ANKK1, TTC12, and NCAM1 polymorphisms and heroin dependence: Importance of considering drug exposure" (2013). Psychiatry Faculty Publications. Paper 1.
Retrieved from https://digitalcommons.wustl.edu/psych_facpubs/1